Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study
Year: 2005
Type: article
Study design: Clinical Trial
Source: Ophthalmology
Authors: S MICHELS, P ROSENFELD, C PULIAFITO, E MARCUS, A VENKATRAMAN
Institution: University of Miami
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2058775052
